Albemarle Corporation
Financials
Valuation Metrics
Albemarle Corporation's Market Cap is $10.73B. At end of 2025 it was $16.65B. Ranked #863 of 3,114 in US market (top 28%), #595 of 1,645 on NYSE (top 36%), #44 of 173 in Materials (top 25%) by Market Cap.
Investment Metrics(as of 2026-10-30)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $10.73B | US#863/3,114 Sec#44/173 |
| Revenue | $5.91B | US#795/3,114 Sec#56/173 |
| Net Income | $224M | US#1,231/3,114 Sec#75/173 |
| Total Assets | $15.91B | US#719/3,114 Sec#40/173 |
| Net Assets | $10.28B | US#411/3,114 Sec#28/173 |
| Employees | 7,800 | US#990/3,114 Sec#55/173 |
| Value | ||
| P/E | 47.88x | US#1,900/3,114 Sec#110/173 |
| P/B | 1.04x | US#464/3,114 Sec#26/173 |
| P/S | 1.82x | US#1,219/3,114 Sec#82/173 |
| EV/EBITDA | 9.01x | US#672/3,114 Sec#71/173 |
| FCF Yield | 12.51% | US#394/3,114 Sec#13/173 |
| Profitability | ||
| ROE | 2.18% | US#2,019/3,114 Sec#115/173 |
| ROA | 1.41% | US#1,804/3,114 Sec#111/173 |
| Op. Margin | 11.92% | US#1,417/3,114 Sec#85/173 |
| Revenue Growth | 18.32% | US#743/3,114 Sec#60/173 |
| Financial Health | ||
| Debt Ratio | 52.67% | US#602/3,114 Sec#52/173 |
| Total Debt | $1.99B | US#1,178/3,114 Sec#61/173 |
| FCF | $1.34B | US#482/3,114 Sec#27/173 |
| Cash | $1.63B | US#494/3,114 Sec#30/173 |
| Current Ratio | 2.09x | US#1,182/3,114 Sec#87/173 |
| Net Debt/EBITDA | 0.29x | US#694/3,114 Sec#47/173 |
| Dividend | ||
| Div. Yield | 1.78% | US#1,028/3,114 Sec#52/173 |
| Div. Growth | 0.90% | US#1,152/3,114 Sec#72/173 |
| Performance | ||
| 1Y Return | -6.75% | US#1,725/3,114 Sec#107/173 |
| 1M Return | -13.96% | US#2,735/3,114 Sec#130/173 |
| From 52W High | -58.82% | US#2,816/3,114 Sec#152/173 |
| 1Y MDD | -57.79% | US#2,657/3,114 Sec#150/173 |
| Trading | ||
| Volume | 1,535,280 shares | US#1,088/3,114 Sec#68/173 |
| Trading Value | $140M | US#683/3,114 Sec#35/173 |
| Per Share | ||
| EPS | $1.90 | US#1,359/3,114 Sec#74/173 |
| BPS | $87.13 | US#151/3,114 Sec#8/173 |
Company Info
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles, power grids and solar panels, high performance greases, specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemicals products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates in the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.